Paxlovid (Nirmatrelvir in combination with ritonavir). They shared initial data in 2022. The study enrolled adult vaccinated patients with COVID-19 who had at least one risk factor for severe ...

Azanza JR, Mensa J, González Del Castillo J, et al. Interactions listed in the Paxlovid fact sheet, classified according to risks, pharmacological groups, and consequences. Rev Esp Quimioter.